Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS)- An integrated analysis of the phase 3 define and confirm studies
Abstract
Authors
A Bar-Or RJ Fox R Gold DH Miller DL Arnold J O'Gorman M Yang SI Sheikh V Viglietta KT Dawson M Hutchinson